PATENT CLAIM ANALYSIS

Application Number: 15875695
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "131100"]

Abstract:
Methods and compositions for enhancing an immune response in a subject (e.g., an immunocompromised subject or a subject with systemic lupus erythematosus (SLE)) are described. In particular, methods of administering to the subject an effective amount of an anti-signaling lymphocytic activation molecule family member 7 (SLAMF7)-antibody or antigen binding fragment thereof are described.

Claim (Index 16):
The method of  claim 15 , wherein the pharmaceutical composition further comprises an adjuvant.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.3617
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14935937', '15142538', '15661584', '10466023', '15239569']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7213099231213318
- 35 USC 102 Novelty (BERT): 0.5316851468857986
- Combined Prediction Score: 0.7023474454977785
- Mean Citation Score: 306.377952
- Max Citation Score: 315.16696
- Similarity Product: 185.8939265047264

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test